News

As the nation focuses on public protests regarding the deaths of black males by white officers, psychiatric groups take notice.

Through archival footage and interviews, the documentary "Prozac: Revolution in a Capsule" does a remarkable job of capturing the time when transformation ignited the collective imagination.

Medication misuse and alcohol abuse are a huge problem in the US, and women and the elderly are not exempt. In this Q&A, an expert touches on the epidemiology, recognition, assessment, and treatment of substance use disorder in these two populations.

In this brief video, an expert summarizes the effects of marijuana use on the teenage brain, as well as new strategies to discuss the consequences of drug use with adolescents.

In this commentary, the author states, “We must get back to treating the whole person, not just his brain circuits. The brain is involved in all we do and what we are, but it is also itself influenced by our psychology and social context.” Care to weigh in?

Because at least 10% of the US population suffers from a substance use disorder in any given year, the American Academy of Addiction Psychiatry has expanded its longstanding Board Review Course in Addictions to a more inclusive “Addictions and Their Treatment” course.

An overview of some of the recent scientific data examining the relationship between adolescent marijuana use and later onset of neuropsychiatric disorders.

This brief communication highlights the importance of genetic predictors and moderators of treatment research in the field of substance use.

An introduction to the Annual Meeting of the American Academy of Addiction Psychiatry and its coverage of topics such as alcohol use disorders, e-cigarettes, prescription opioid use and abuse, cannabis use, stimulant use, medical marijuana, gambling, and opioid antagonist therapy to prevent overdose.

The past decade has been an exciting one for the field of psychosomatic medicine. It has been recognized as a specialty and now has a certification examination. In this Special Report, we discuss some of the approaches that are being taken to special populations within the psychosomatic medicine community.

This article provides a practical framework that can guide consultation-liaison psychiatrists through solving problems of capacity and informed consent.

Although the somatizing disorders cover a vast array of symptomatic domains across many medical specialties, this article addresses the broad topic conceptually.

The need to integrate psychiatric treatment with somatic care puts psychosomatic medicine in a unique position to focus on older patients who would not otherwise seek specialized treatment.

For severely ill patients, understanding the neurobiological underpinning of assertive coping provides an additional map for rapid assessment, formulation, and intervention to bolster assertive coping.

An overview of select topics in clinical psycho-oncology, including assessment and management of delirium and brain lesions, mood and anxiety disorders, medication adverse effects, and existential death anxiety.

The role of transplant psychiatrists is to assess both transplant and donor candidates to determine capacity to consent to the surgery, recent stressors and coping skills, social supports and availability of caregivers, and whether there are psychological or substance abuse issues that would affect outcomes.

Key issues about geriatric bipolar disorder-epidemiology, assessment, medical and psychiatric comorbidity, and treatment-are the focus.

There are a considerable number of aging patients with an eating disorder who have only partial symptom remission or who remain ill for many decades. Here is a case in point.

Who hasn’t been at a public gathering and, after identifying yourself as a psychiatrist, heard someone respond nervously, “Can you read my mind?” Just as Thanksgiving can be compromised by family conflict, being a psychiatrist can at times feel like a curse in our public lives.

The case for training residents to conduct evaluations of impairments in patients with chronic mental health issues.

This volume is written from an emerging edge of basic science and will reward a clinical readership.

Here: the case of a woman with bipolar disorder who was admitted for aggressive behavior and nonadherence to medications. Art therapy and pharmacotherapy played a pivotal role in her recovery.

Psychiatrists should be playing a key role in end-of-life decisions as well as, not coincidentally, in pain management.

What signs are generally regarded as negative symptoms? What etiological factors contribute to a negative symptom presentation? How to treat these symptoms? Insights here.

There are probably many social, economic, and familial forces at work in generating the trend toward public incivility, and it would be silly to blame the Internet for the riot in Keene.

This psychiatrist takes notice when he hears public remarks by celebrities on their alleged psychiatric illnesses. A perfect example is when Jerry Seinfeld claimed he was “a bit autistic” to Brian Williams on NBC Nightly News.

This article reviews the reasons for measuring serum levels of psychotropics and provides optimum serum levels for various psychotropic agents to optimize their effectiveness and safety.

The use of buprenorphine for the treatment of opioid dependence is on the rise. However, buprenorphine withdrawal has its own withdrawal symptoms that in many cases can be as severe as symptoms of opioid withdrawal.

This study highlights the need to consider a holistic approach when discussing the problem of disruptive behavior in health care settings.

Although the early focus of the NIH component of the BRAIN Initiative is on tool development, the examples listed in this article show that these tools will have relevance to practicing clinicians within the lifetime of the Initiative.